STOCK TITAN

NEXGEL (NXGL) CEO acquires convertible note and 50,000-share stock warrant

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

NEXGEL, INC. reported that Chief Executive Officer Adam R. Levy acquired derivative securities linked to its common stock. He received a Convertible Promissory Note with an original principal amount of $60,000, which is convertible into up to 100,000 shares of common stock at $0.60 per share. He also received a Warrant to Purchase Common Stock for 50,000 shares at an initial exercise price of $0.80 per share, issued as part of the consideration for purchasing the note. Both the note and warrant are exercisable at any time at his option, subject to a 4.99% beneficial-ownership limitation that restricts conversion or exercise if it would push ownership above that threshold.

Positive

  • None.

Negative

  • None.
Insider Levy Adam R.
Role Chief Executive Officer
Bought 150,000 shs ($60K)
Type Security Shares Price Value
Purchase Convertible Promissory Note (the "Note") 100,000 $0.60 $60K
Purchase Warrant to Purchase Common Stock (the "Warrant") 50,000 $0.00 --
Holdings After Transaction: Convertible Promissory Note (the "Note") — 100,000 shares (Direct, null); Warrant to Purchase Common Stock (the "Warrant") — 50,000 shares (Direct, null)
Footnotes (1)
  1. Reflects the issuance to the Reporting Person of (i) a Convertible Promissory Note in the original principal amount of $60,000 (the "Note") and (ii) a Warrant to Purchase Common Stock for 50,000 shares of the Issuer's common stock (the "Common Stock") (the "Warrant").The Note is convertible into up to 100,000 shares of Common Stock at an initial conversion price of $0.60 per share, and the Warrant is exercisable for 50,000 shares of Common Stock at an initial exercise price of $0.80 per share. The Note is convertible, and the Warrant is exercisable, at any time at the option of the holder, subject to (i) a beneficial-ownership limitation that prevents conversion or exercise to the extent the holder, together with its affiliates, would beneficially own more than 4.99% of the outstanding shares of Common Stock after such conversion or exercise, and (ii) certain other limitations set forth in the Note and Warrant. The Warrant was issued to the Reporting Person in connection with, and as part of the consideration for, the Reporting Person's purchase of the Note, for no additional consideration beyond the Note purchase price.
Convertible note principal $60,000 Original principal amount of the Convertible Promissory Note
Note conversion price $0.60/share Initial conversion price for up to 100,000 common shares
Shares underlying note 100,000 shares Common stock underlying the Convertible Promissory Note
Warrant share count 50,000 shares Common stock purchasable under the warrant
Warrant exercise price $0.80/share Initial exercise price for the warrant
Beneficial-ownership cap 4.99% Maximum post-transaction ownership allowed under note and warrant
Warrant expiration May 14, 2031 Expiration date of the warrant to purchase common stock
Note expiration November 14, 2027 Expiration date for the Convertible Promissory Note
Convertible Promissory Note financial
"Reflects the issuance to the Reporting Person of (i) a Convertible Promissory Note in the original principal amount of $60,000"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
Warrant to Purchase Common Stock financial
"and (ii) a Warrant to Purchase Common Stock for 50,000 shares of the Issuer's common stock"
beneficial-ownership limitation regulatory
"subject to (i) a beneficial-ownership limitation that prevents conversion or exercise to the extent the holder"
outstanding shares of Common Stock financial
"would beneficially own more than 4.99% of the outstanding shares of Common Stock after such conversion or exercise"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levy Adam R.

(Last)(First)(Middle)
C/O NEXGEL, INC.
2150 CABOT BLVD, WEST, SUITE B

(Street)
LANGHORNE PENNSYLVANIA 19047

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Convertible Promissory Note (the "Note")(1)$0.605/14/2026P100,00005/14/202611/14/2027Common Stock100,000$0.6100,000D
Warrant to Purchase Common Stock (the "Warrant")(1)(2)$0.805/14/2026P50,00005/14/202605/14/2031Common Stock50,000$0.00(2)50,000D
Explanation of Responses:
1. Reflects the issuance to the Reporting Person of (i) a Convertible Promissory Note in the original principal amount of $60,000 (the "Note") and (ii) a Warrant to Purchase Common Stock for 50,000 shares of the Issuer's common stock (the "Common Stock") (the "Warrant").The Note is convertible into up to 100,000 shares of Common Stock at an initial conversion price of $0.60 per share, and the Warrant is exercisable for 50,000 shares of Common Stock at an initial exercise price of $0.80 per share. The Note is convertible, and the Warrant is exercisable, at any time at the option of the holder, subject to (i) a beneficial-ownership limitation that prevents conversion or exercise to the extent the holder, together with its affiliates, would beneficially own more than 4.99% of the outstanding shares of Common Stock after such conversion or exercise, and (ii) certain other limitations set forth in the Note and Warrant.
2. The Warrant was issued to the Reporting Person in connection with, and as part of the consideration for, the Reporting Person's purchase of the Note, for no additional consideration beyond the Note purchase price.
/s/ Adam Levy05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did NEXGEL (NXGL) CEO Adam R. Levy acquire in this Form 4?

NEXGEL’s CEO Adam R. Levy acquired a Convertible Promissory Note and a stock purchase warrant. The note can convert into up to 100,000 common shares, and the warrant allows purchase of 50,000 shares, both at fixed prices and under ownership limits.

What are the key terms of the NEXGEL (NXGL) convertible promissory note?

The Convertible Promissory Note has an original principal of $60,000 and is convertible into up to 100,000 NEXGEL common shares at $0.60 per share. It is convertible at any time at the holder’s option, subject to a 4.99% beneficial-ownership cap.

What are the main terms of the NEXGEL (NXGL) stock purchase warrant?

The warrant allows the CEO to acquire 50,000 NEXGEL common shares at an initial exercise price of $0.80 per share. It is exercisable at any time at his option, but exercises are limited by a 4.99% beneficial-ownership restriction.

How many NEXGEL (NXGL) shares are underlying the CEO’s new securities?

The CEO’s new securities are linked to up to 150,000 NEXGEL common shares. The convertible note is tied to 100,000 shares at $0.60 per share, and the warrant covers 50,000 shares at an initial exercise price of $0.80 per share.

What is the beneficial-ownership limitation in the NEXGEL (NXGL) CEO’s note and warrant?

Both the note and warrant include a 4.99% beneficial-ownership limitation. This prevents conversions or exercises if they would cause the holder, together with affiliates, to own more than 4.99% of NEXGEL’s outstanding common stock after the transaction.

Why did NEXGEL (NXGL) issue a warrant to its CEO with the note purchase?

NEXGEL issued the 50,000-share warrant to its CEO as part of the consideration for his purchase of the $60,000 Convertible Promissory Note. The footnote states the warrant was granted for no additional consideration beyond the note’s purchase price.